Founded in 2010, Tillotts Pharma Uk, classified under reg no. 07186552 is an active company. Currently registered at Larbourne Suite The Stables LN5 0HX, Wellingore the company has been in the business for fourteen years. Its financial year was closed on 31st December and its latest financial statement was filed on 2022-12-31.
At the moment there are 3 directors in the the company, namely Marcel P., Barbara L. and Jeremy T.. In addition one secretary - Lisa R. - is with the firm. At the moment there are several former directors listed by the company. Their names might be found in the box below. In addition, there is one former secretary - Helen J. who worked with the the company until 16 March 2020.
Office Address | Larbourne Suite The Stables |
Office Address2 | Wellingore Hall |
Town | Wellingore |
Post code | LN5 0HX |
Country of origin | United Kingdom |
Registration Number | 07186552 |
Date of Incorporation | Thu, 11th Mar 2010 |
Industry | Other business support service activities not elsewhere classified |
End of financial Year | 31st December |
Company age | 14 years old |
Account next due date | Mon, 30th Sep 2024 (155 days left) |
Account last made up date | Sat, 31st Dec 2022 |
Next confirmation statement due date | Mon, 25th Mar 2024 (2024-03-25) |
Last confirmation statement dated | Sat, 11th Mar 2023 |
The list of PSCs who own or control the company is made up of 1 name. As we established, there is Zeria Pharmaceutical Co.,Ltd from Tokyo, Japan. This PSC is categorised as "a company limited by shares", has significiant influence or control over the company. This PSC has significiant influence or control over this company,.
Zeria Pharmaceutical Co.,Ltd
10-11 Nihonbashi Kobuna-Cho, Chuo-Ku, Tokyo, Japan
Legal authority | Japanese |
Legal form | Company Limited By Shares |
Country registered | Japan |
Place registered | Japan |
Registration number | 0100-01-034790 |
Notified on | 5 March 2024 |
Nature of control: |
significiant influence or control |
Profit & Loss | ||||||||
---|---|---|---|---|---|---|---|---|
Accounts Information Date | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
Balance Sheet | ||||||||
Cash Bank On Hand | 2 776 071 | 4 427 103 | 1 341 417 | 1 198 496 | 8 031 691 | 6 203 086 | 12 228 580 | 5 511 546 |
Current Assets | 12 736 774 | 13 840 558 | 21 231 324 | 15 980 641 | 32 510 966 | 34 770 029 | 34 467 556 | 31 475 606 |
Debtors | 5 041 828 | 4 388 439 | 5 070 496 | 6 807 519 | 6 906 151 | 10 830 121 | 9 601 831 | 18 344 721 |
Other Debtors | 1 033 | 1 033 | 1 033 | 1 033 | 1 033 | 1 033 | 1 033 | 1 033 |
Total Inventories | 4 918 875 | 5 025 016 | 14 819 411 | 7 974 626 | 17 573 124 | 17 736 822 | 12 637 145 | 7 619 339 |
Other | ||||||||
Audit Fees Expenses | 10 000 | 10 000 | 10 000 | 10 300 | 10 300 | 10 600 | 11 200 | 11 760 |
Audit-related Assurance Services Fees | 47 176 | 8 860 | ||||||
Company Contributions To Money Purchase Plans Directors | 13 255 | 14 187 | 17 350 | 20 150 | 19 407 | 19 407 | 19 407 | 19 407 |
Director Remuneration | 182 493 | 180 042 | 192 108 | 239 024 | 211 812 | 228 189 | 244 968 | 256 604 |
Number Directors Accruing Benefits Under Money Purchase Scheme | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
Accrued Liabilities Deferred Income | 734 479 | 465 490 | 1 048 183 | 1 584 667 | 1 265 392 | 1 649 253 | 2 861 406 | 4 247 379 |
Administrative Expenses | 4 712 780 | 5 613 097 | 6 302 540 | 6 690 902 | 6 112 806 | 6 975 864 | 8 901 640 | 8 341 797 |
Amounts Owed By Group Undertakings | 413 350 | 78 914 | 429 270 | |||||
Amounts Owed To Group Undertakings | 8 715 734 | 10 089 659 | 16 017 461 | 9 773 383 | 25 295 332 | 25 566 864 | 22 388 975 | 16 963 716 |
Applicable Tax Rate | 20 | 20 | 19 | 19 | 19 | 19 | 19 | 25 |
Average Number Employees During Period | 23 | 28 | 35 | 37 | 36 | 37 | 40 | 41 |
Cash Cash Equivalents Cash Flow Value | 2 776 071 | 1 341 417 | 1 198 496 | 8 031 691 | 6 203 086 | 12 228 580 | ||
Comprehensive Income Expense | 680 578 | 503 036 | 830 683 | 707 381 | 1 165 854 | 1 129 584 | 1 232 306 | 1 288 219 |
Corporation Tax Payable | 94 278 | 94 711 | 93 803 | 86 045 | 156 683 | 135 492 | 92 909 | 184 454 |
Cost Sales | 13 217 743 | 15 710 862 | 18 045 208 | 21 378 956 | 27 176 828 | 29 367 878 | 33 664 220 | 43 143 707 |
Creditors | 10 747 563 | 11 348 311 | 17 908 394 | 11 950 330 | 27 314 801 | 28 444 280 | 26 909 501 | 22 629 332 |
Current Tax For Period | 142 212 | 174 710 | 183 206 | 165 852 | 273 880 | 265 357 | 289 016 | 403 871 |
Further Item Interest Expense Component Total Interest Expense | 55 000 | 53 944 | 31 354 | 391 143 | 29 935 | 313 526 | 450 941 | 824 216 |
Further Operating Expense Item Component Total Operating Expenses | 42 482 | 57 221 | 49 369 | 29 149 | 6 491 | 34 615 | 34 615 | 34 615 |
Future Minimum Lease Payments Under Non-cancellable Operating Leases | 35 816 | 46 679 | 36 460 | 1 515 | 34 615 | 34 615 | 20 192 | 34 615 |
Gain Loss Due To Foreign Exchange Differences Recognised In Profit Or Loss | -5 469 | 6 066 | 2 285 | -4 475 | 1 254 | 3 275 | -19 446 | 2 715 |
Gain Loss In Cash Flows From Change In Creditors Trade Other Payables | 3 907 578 | 1 600 315 | 6 560 991 | -6 967 247 | 16 310 774 | -5 786 800 | 1 097 084 | 10 947 457 |
Gain Loss In Cash Flows From Change In Debtors Trade Other Receivables | -872 642 | 653 389 | -682 057 | -1 737 023 | -98 632 | -3 923 970 | 1 228 290 | -8 742 890 |
Gross Profit Loss | 5 566 565 | 6 305 891 | 7 278 078 | 7 932 287 | 7 376 946 | 8 661 061 | 10 871 961 | 10 755 323 |
Income Taxes Paid Refund Classified As Operating Activities | -91 000 | -156 358 | -137 404 | -173 610 | -203 242 | -286 548 | -331 599 | -312 326 |
Increase Decrease In Cash Cash Equivalents Before Foreign Exchange Differences Changes In Consolidation | 1 597 252 | 1 651 032 | -3 085 686 | -142 921 | 6 833 195 | -1 828 605 | 6 025 494 | -6 717 034 |
Increase Decrease In Current Tax From Adjustment For Prior Periods | -17 919 | -46 710 | -35 | |||||
Increase Decrease In Stocks Inventories Finished Goods Work In Progress | 2 169 474 | 106 141 | 9 794 395 | -6 844 785 | 9 598 498 | 163 698 | -5 099 677 | -5 017 806 |
Interest Income On Bank Deposits | 5 550 | 801 | 3 659 | 3 655 | 1 230 | 160 | 292 | 102 180 |
Interest Paid Classified As Operating Activities | -55 000 | -53 944 | -31 354 | -391 143 | -29 935 | -313 526 | -450 941 | -824 216 |
Interest Payable Similar Charges Finance Costs | 55 000 | 53 944 | 31 354 | 391 143 | 29 935 | 313 526 | 450 941 | 824 216 |
Merchandise | 4 918 875 | 5 025 016 | 14 819 411 | 7 974 626 | 17 573 124 | 17 736 822 | 12 637 145 | 7 619 339 |
Net Cash Flows From Used In Financing Activities | 1 000 000 | -1 016 941 | 1 016 941 | -6 937 470 | 2 589 280 | 15 319 171 | ||
Net Cash Flows From Used In Investing Activities | -5 550 | -801 | -3 659 | -3 655 | -1 230 | -160 | -292 | -102 180 |
Net Cash Flows From Used In Operating Activities | -1 591 702 | -2 650 231 | 3 089 345 | 1 163 517 | -7 848 906 | 8 766 235 | -8 614 482 | -8 499 957 |
Net Cash Generated From Operations | -1 737 702 | -2 860 533 | 2 920 587 | 598 764 | -8 082 083 | 8 166 161 | -9 397 022 | -9 636 499 |
Net Current Assets Liabilities | 1 989 211 | 2 492 247 | 3 322 930 | 4 030 311 | 5 196 165 | 6 325 749 | 7 558 055 | 8 846 274 |
Net Interest Received Paid Classified As Investing Activities | -5 550 | -801 | -3 659 | -3 655 | -1 230 | -160 | -292 | -102 180 |
Number Shares Issued Fully Paid | 20 000 | 20 000 | 20 000 | 20 000 | 20 000 | 20 000 | 20 000 | |
Operating Profit Loss | 872 240 | 712 970 | 994 874 | 1 260 721 | 1 468 439 | 1 708 307 | 1 971 971 | 2 414 126 |
Other Interest Receivable Similar Income Finance Income | 5 550 | 801 | 3 659 | 3 655 | 1 230 | 160 | 292 | 102 180 |
Other Operating Income Format1 | 18 455 | 20 176 | 19 336 | 19 336 | 204 299 | 23 110 | 1 650 | 600 |
Other Taxation Social Security Payable | 55 114 | 68 657 | 64 400 | 74 114 | 77 785 | 79 761 | 163 731 | 8 690 |
Par Value Share | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
Pension Other Post-employment Benefit Costs Other Pension Costs | 73 213 | 83 464 | 110 438 | 120 957 | 123 399 | 147 471 | 167 609 | 159 877 |
Prepayments Accrued Income | 200 480 | 156 008 | 153 654 | 219 687 | 246 956 | 379 413 | 133 283 | 212 462 |
Profit Loss | 680 578 | 503 036 | 830 683 | 707 381 | 1 165 854 | 1 129 584 | 1 232 306 | 1 288 219 |
Profit Loss On Ordinary Activities Before Tax | 822 790 | 659 827 | 967 179 | 873 233 | 1 439 734 | 1 394 941 | 1 521 322 | 1 692 090 |
Repayments Borrowings Classified As Financing Activities | -1 000 000 | -7 073 701 | -1 016 941 | -2 589 280 | -15 319 171 | |||
Social Security Costs | 193 761 | 227 329 | 281 117 | 337 308 | 312 592 | 369 365 | 493 690 | 409 553 |
Staff Costs Employee Benefits Expense | 1 831 429 | 2 079 210 | 2 593 053 | 2 768 197 | 2 935 862 | 3 266 133 | 4 038 959 | 3 776 803 |
Tax Expense Credit Applicable Tax Rate | 164 558 | 131 965 | 183 764 | 165 914 | 273 549 | 265 039 | 289 051 | 423 023 |
Tax Increase Decrease From Effect Different Tax Rates On Some Earnings | -19 152 | |||||||
Tax Tax Credit On Profit Or Loss On Ordinary Activities | 142 212 | 156 791 | 136 496 | 165 852 | 273 880 | 265 357 | 289 016 | 403 871 |
Total Assets Less Current Liabilities | 1 989 211 | 2 492 247 | 3 322 930 | 4 030 311 | 5 196 165 | 6 325 749 | 7 558 055 | 8 846 274 |
Trade Creditors Trade Payables | 205 933 | 405 701 | 364 160 | 32 865 | 81 821 | 303 538 | 607 728 | 446 485 |
Trade Debtors Trade Receivables | 4 426 965 | 4 231 398 | 4 836 895 | 6 586 799 | 6 658 162 | 10 449 675 | 9 038 245 | 18 131 226 |
Turnover Revenue | 18 784 308 | 22 016 753 | 25 323 286 | 29 311 243 | 34 553 774 | 38 028 939 | 44 536 181 | 53 899 030 |
Wages Salaries | 1 564 455 | 1 768 417 | 2 201 498 | 2 309 932 | 2 499 871 | 2 749 297 | 3 377 660 | 3 207 373 |
Proceeds From Borrowings Classified As Financing Activities | -8 090 642 | -6 937 470 | ||||||
Tax Increase Decrease From Other Tax Effects Tax Reconciliation | -558 | -62 | 331 |
Type | Category | Free download | |
---|---|---|---|
AA |
Full accounts data made up to 2022-12-31 filed on: 30th, March 2023 |
accounts | Free Download (22 pages) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy